La pandemia del coronavirus ha puesto de manifiesto algunas fortalezas de nuestro Sistema Nacional de Salud, pero también debilidades, y esto ha contribuido el convencimiento general de la necesidad ...
Read moreIn the last 18 months 4 new hospital spin-off have been approved with the support of GENESIS Biomed
Read moreOncoDNA, compañía especializada en medicina de precisión para el tratamiento y diagnóstico del cáncer, ha sido nominada para el premio BVA Award Growth Company of the Year 2020, un galardón conc...
Read moreLa compañía biotecnológica Algenex ha cerrado una ronda de financiación privada por valor de 7,4 millones de euros liderada por MasterLux, inversor asesorado por Cleon Capital y Vita Advisory. Est...
Read moreGEN inCode - sociedad de capital privado de inteligencia artificial especializada en la prevención de enfermedades cardiovasculares -, ha anunciado el cierre de una ronda de inversión institucional ...
Read moreSartorius, a leading international partner of life science research and the biopharmaceutical industry, successfully placed a note loan with a volume of 750 million euros.
Read moreLa iniciativa "Precipita", de FECYT, permite colaborar con personal investigador de la Universidad de Oviedo, a través de donaciones, para que desarrolle y valide una herramienta de predicción. La d...
Read moreSplice Bio, a biotech company based on technology developed in the Muir Lab at Princeton University, announced today a new investment into the Company led by Ysios Capital and joined by Asabys Partner...
Read moreSartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, will soon be listed on the French stock index CAC Next 20 and therefore also on the CAC Large 60 index. Acc...
Read moreConnecta Therapeutics has closed a €1.7 million round of investment led by Inveready that will allow the company to take its first drug through to phase IIa clinical trials in patients who have frag...
Read moreAsabys Partners, a venture capital firm and member of CataloniaBio & HealthTech, has participated in Medasense Biometrics Ltd’s €15.2-million Series C round of funding along with investors such as...
Read moreFunds will support preparations for potential EU conditional approval of GB0139 in IPF and multiple new Phase 2 clinical trials
Read more